Commitment to Patient Safety
RTI is committed to providing safe and high quality grafts for use in spine, sports medicine, orthopedic, dental and other surgical specialties.
RTI adheres to strict, scientific screening criteria and validated sterilization methods to ensure the safety of these allografts.
Patient Safety Through Redundant Safeguards
RTI’s primary goal is to ensure recipient safety. The safety of tissue is contingent upon three stages – donor screening, laboratory testing and processing methods validated to address potential disease transmission. In the event that one of these stages is challenged, RTI’s built-in redundancies continue to ensure a high level of patient safety.
Standards That Meet or Exceed Regulations
Maintaining our commitment to provide safe allograft implants, our quality assurance team ensures that all of the aspects of the donation process meet the standards and guidance of federal, state and local requirements, as well as the American Association of Tissue Banks (AATB). Our team works closely with our recovery agencies to review and provide feedback regarding relevant policies, procedures and donor documentation.
Allografts are used in more than 1.5 million surgical procedures annually for transplant in the United States. Although the risk of disease transmission through allograft transplantation is low due to screening and testing methods, RTI’s proprietary, validated sterilization processes reduce this risk even further. Two such processes – BioCleanse ® Tissue Sterilization Process and the Tutoplast ® process – have a proven combined record of more than two million implants distributed with zero incidence of allograft associated infection.